Literature DB >> 16900778

The normal human amniotic fluid supernatant proteome.

George T Tsangaris1, Ageliki Kolialexi, Panagiotis M Karamessinis, Athanasios K Anagnostopoulos, Aris Antsaklis, Michael Fountoulakis, Ariadni Mavrou.   

Abstract

Proteomic analysis combining two-dimentional electrophoresis (2DE) and mass spectrometry (MS) has the potential for a wide range of applications in biological and medical sciences, as protein screening in tissues obtained from healthy and diseased conditions can determine drug targets and diagnostic markers. Conventionally, amniotic fluid (AF) samples are routinely used for prenatal diagnosis of a wide range of fetal abnormalities. Proteomics have already been applied in the analysis of tissues from fetuses with Down's syndrome, in order to detect differences in their protein profile as compared to the normal profiles and to determine possible diagnostic tools. A detailed protein 2DE for the normal human AF has not been reported. In the present study, the 2D protein database of the normal human AF supernatant (AFS) was constructed. Ten AFS samples from women carrying normal fetuses were analysed by 2DE. A mean of 412 spots per gel were analyzed and protein identification was carried out by MALDI-MS and MALDI-MS-MS. A 2D protein map comprising of 136 different gene products was constructed. The majority of the identified proteins are regulatory proteins, enzymes, secreted proteins, carriers and immunoglobulins. Twelve hypothetical proteins were also included. The normal AFS proteome map is a valuable tool for the study of aberrant protein expression and the search for proteins as possible markers for the prediction of abnormal fetuses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900778

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  15 in total

Review 1.  Cell-free fetal nucleic acids in amniotic fluid.

Authors:  L Hui; D W Bianchi
Journal:  Hum Reprod Update       Date:  2010-10-05       Impact factor: 15.610

2.  Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.

Authors:  Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-26

3.  High-throughput discovery and characterization of fetal protein trafficking in the blood of pregnant women.

Authors:  Jill L Maron; Gil Alterovitz; Marco Ramoni; Kirby L Johnson; Diana W Bianchi
Journal:  Proteomics Clin Appl       Date:  2009-12       Impact factor: 3.494

4.  More than fetal urine: enteral uptake of amniotic fluid as a major predictor for fetal growth during late gestation.

Authors:  Soyhan Bagci; Erwin Brosens; Dick Tibboel; Annelies De Klein; Hanneke Ijsselstijn; Charlotte H W Wijers; Nel Roeleveld; Ivo de Blaauw; Paul M Broens; Iris A L M van Rooij; Alice Hölscher; Thomas M Boemers; Marcus Pauly; Oliver J Münsterer; Eberhard Schmiedeke; Mattias Schäfer; Benno E Ure; Martin Lacher; Vera Choinitzki; Johannes Schumacher; Nadine Zwink; Ekkehart Jenetzky; David Katzer; Joerg Arand; Peter Bartmann; Heiko M Reutter
Journal:  Eur J Pediatr       Date:  2016-03-16       Impact factor: 3.183

5.  Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.

Authors:  Emmanuel Bujold; Roberto Romero; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jimmy Espinoza; Edi Vaisbuch; Yeon Mee Kim; Samuel Edwin; Mike Pisano; Beth Allen; Vladimir N Podust; Enrique A Dalmasso; Jennifer Rutherford; Wade Rogers; Allan Moser; Bo Hyun Yoon; Tim Barder
Journal:  J Matern Fetal Neonatal Med       Date:  2008-10

6.  Zinc-α2-glycoprotein is unrelated to gestational diabetes: anthropometric and metabolic determinants in pregnant women and their offspring.

Authors:  Silvia Näf; Xavier Escote; Rosa Elena Yañez; Mónica Ballesteros; Inmaculada Simón; Pilar Gil; Ana Megia; Joan Vendrell
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

7.  Proteomics in obstetrics and gynecology.

Authors:  Seema Lekhwani; Vijay Shankar; N D Vaswani
Journal:  Indian J Hum Genet       Date:  2011-01

8.  Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ).

Authors:  Varaprasad Kolla; Paul Jenö; Suzette Moes; Sevgi Tercanli; Olav Lapaire; Mahesh Choolani; Sinuhe Hahn
Journal:  J Biomed Biotechnol       Date:  2009-11-05

9.  Application of proteomics for the identification of biomarkers in amniotic fluid: are we ready to provide a reliable prediction?

Authors:  George Th Tsangaris; Athanasios K Anagnostopoulos; Georgia Tounta; Aris Antsaklis; Ariadni Mavrou; Aggeliki Kolialexi
Journal:  EPMA J       Date:  2011-06-19       Impact factor: 6.543

10.  Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids.

Authors:  Alain Mange; Caroline Desmetz; Virginie Bellet; Nicolas Molinari; Thierry Maudelonde; Jerome Solassol
Journal:  Proteome Sci       Date:  2008-01-11       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.